BlackRock Amends Insulet Corp. Stake, Signals Passive Investment
Ticker: PODD · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1145197
| Field | Detail |
|---|---|
| Company | Insulet Corp (PODD) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its Insulet stake, still a major passive holder.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Insulet Corporation's common stock as of December 31, 2023. This filing, Amendment No. 4, updates BlackRock's previous disclosures regarding its passive investment in Insulet, a medical device company. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal its confidence (or lack thereof) in Insulet's future performance, potentially influencing other investors.
Why It Matters
This filing shows BlackRock's continued significant, but passive, investment in Insulet, which can reassure other investors about the stock's institutional backing.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor, indicating a passive stake, which generally poses low risk.
Analyst Insight
Investors should note BlackRock's continued passive stake in Insulet, which suggests a long-term, non-activist investment perspective. This filing doesn't indicate any immediate need for action but confirms institutional interest.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Insulet Corporation (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the filing date of the SC 13G/A
- 45784P101 (other) — the CUSIP number for Insulet Corporation's Common Stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4)'.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., as stated under '(1)Names of reporting persons. BlackRock, Inc.' and in the 'FILED BY' section.
What is the subject company whose securities are being reported?
The subject company is INSULET CORPORATION, as indicated by '(Name of Issuer) INSULET CORPORATION' and in the 'SUBJECT COMPANY' data section.
What is the CUSIP number for the securities reported?
The CUSIP number for the Common Stock of Insulet Corporation is 45784P101, as listed under 'CUSIP No. 45784P101'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as stated under '(Date of Event Which Requires Filing of this Statement) December 31, 2023'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding INSULET CORP (PODD).